Ghatnekar, O.; Hjalte, F.; Taylor, M. Cost-Effectiveness of Dasatinib Versus High-Dose Imatinib in Patients With Chronic Myeloid Leukemia (CML), Resistant to Standard Dose Imatinib – a Swedish Model Application. AO 2010, 49, 851-858.